JABBAAR, IBNU (2020) PENGARUH ASET TIDAK BERWUJUD, R&D, DAN KINERJA KEUANGAN TERHADAP NILAI PASAR PERUSAHAAN (STUDI PADA PERUSAHAAN FARMASI YANG TERDAFTAR DI BEI PERIODE 2014 – 2018). S1 thesis, Universitas Negeri Jakarta.
Text
Cover.pdf Download (380kB) |
|
Text
Table_Of_Content.pdf Download (114kB) |
|
Text
Chapter1.pdf Download (309kB) |
|
Text
Chapter2.pdf Restricted to Repository staff only Download (481kB) |
|
Text
Chapter3.pdf Download (458kB) |
|
Text
Chapter4.pdf Restricted to Repository staff only Download (738kB) |
|
Text
Chapter5.pdf Download (12kB) |
|
Text
Bibliography.pdf Download (117kB) |
Abstract
IBNU JABBAAR. Influence of Intangible Assets, R&D, and Financial Performance on the Market Value of Pharmaceutical Companies Listed in BEI 2014 - 2018 Period. This study aims to examine the effect of intangible assets, R&D, and financial performance on the value of pharmaceutical companies registered in the period of 2014 - 2018. This research uses secondary data with the population of all pharmaceutical companies on the Indonesia Stock Exchange in 2014 - 2018. In this study a purposive sampling method was used in which 35 samples were obtained overall. This study uses multiple linear regression to test hypotheses at the 5% significance level. From the analysis performed in this research result, it was found that only intangible asset (INTAV) had a positive and significant effect on firm value. While the R&D and ROA variables have a negative and not significant effect on the company’s market value. Keywords: Intangible Assets, R&D, Financial Performance, Firm Value
Actions (login required)
View Item |